Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE DE LA HAUTE FOLIE : revenue, balance sheet and financial ratios

PHARMACIE DE LA HAUTE FOLIE is a French company founded 7 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in HEROUVILLE SAINT CLAIR (14200), this company of category PME shows in 2024 a net income positive of 14 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-18

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Historique financier - PHARMACIE DE LA HAUTE FOLIE (SIREN 844719468)
Kennzahl 2024 2023 2021 2020 2019
Umsatz N/C N/C N/C N/C N/C
Nettoergebnis 14 192 € 47 574 € 105 510 € 90 530 € 32 856 €
EBITDA N/C N/C N/C N/C N/C
Nettomarge N/C N/C N/C N/C N/C

Umsatz und Gewinn- und Verlustrechnung

In 2024, PHARMACIE DE LA HAUTE FOLIE generates positive net income of 14 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2024: 33 k€ -> 14 k€.

Nettoergebnis (2024) ?
Nettoergebnis
Definition
Bénéfice ou perte après toutes les charges, y compris impôts et éléments exceptionnels.
Formel
Ordentliches Ergebnis + Außerordentliches Ergebnis - Ertragsteuern

14 192 €

Chargement du compte de résultat...

Évolution graphique

Anzeigen :

Aktiva

Chargement des données...

Passiva

Chargement des données...

Solvenz- und Verschuldungskennzahlen

The debt ratio (= Financial debt / Equity x 100) stands at 1866%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 4%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Verschuldungsgrad (2024) ?
Verschuldungsgrad
Definition
Misst das Verhältnis von Schulden zu Eigenkapital.
Formel
(Finanzschulden / Eigenkapital) x 100
Interpretation
< 50% : Faible
50-100% : Moderat
> 100% : Hoch

1866.01%

Finanzielle Autonomie (2024) ?
Finanzielle Autonomie
Definition
Anteil des Eigenkapitals an der Gesamtfinanzierung.
Formel
(Eigenkapital / Bilanzsumme) x 100
Interpretation
> 30% : Gute Autonomie
20-30% : Durchschnitt
< 20% : Faible

4.079%

Anlagenaltersquote (2024) ?
Anlagenaltersquote
Definition
Misst den Abnutzungsgrad des Sachanlagevermögens.
Formel
Kumulierte Abschreibungen / Bruttoanlagevermögen x 100
Interpretation
< 50% : Neue Anlagen
50-70% : Normale Abnutzung
> 70% : Alternde Anlagen

44.6%

Entwicklung der Solvenzkennzahlen
PHARMACIE DE LA HAUTE FOLIE

Positionnement sectoriel

Debt ratio
1866.01 2024
2021
2023
2024
Q1: 16.45
Méd: 58.41
Q3: 154.59
Average

In 2024, the debt ratio of PHARMACIE DE LA HAUTE FOLIE (1866.01) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
4.08% 2024
2021
2023
2024
Q1: 28.92%
Méd: 49.95%
Q3: 69.49%
Watch

In 2024, the financial autonomy of PHARMACIE DE LA HAUTE FOLIE (4.1%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Liquiditätskennzahlen

The liquidity ratio (= Current assets / Current liabilities) stands at 83.90. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquiditätsquote (2024) ?
Liquiditätsquote
Definition
Fähigkeit, kurzfristige Schulden mit dem Umlaufvermögen zu decken.
Formel
Umlaufvermögen / Kurzfristige Verbindlichkeiten
Interpretation
> 1.5 : Sehr gut
1-1.5 : Angemessen
< 1 : Risque de liquidité

83.901

Entwicklung der Liquiditätskennzahlen
PHARMACIE DE LA HAUTE FOLIE

Positionnement sectoriel

Liquidity ratio
83.9 2024
2021
2023
2024
Q1: 129.47
Méd: 182.14
Q3: 260.79
Watch -7 pts über 3 Jahre

In 2024, the liquidity ratio of PHARMACIE DE LA HAUTE FOLIE (83.90) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Positionnement de PHARMACIE DE LA HAUTE FOLIE dans son secteur

Vergleich mit der Branche Commerce de détail de produits pharmaceutiques en magasin spécialisé

Bewertungsschätzung

Based on 225 transactions of similar company sales in 2024, the value of PHARMACIE DE LA HAUTE FOLIE is estimated at 198 130 € (range 137 975€ - 296 415€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
137k€ 198k€ 296k€
198 130 € Range: 137 975€ - 296 415€
NAF 5 année 2024

Valuation method used

Net Income Multiple
14 192 € × 14.0x = 198 131 €
Range: 137 975€ - 296 415€

Only this financial indicator is available for this company.

Bewertungsentwicklung

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE DE LA HAUTE FOLIE with other companies in the same sector:

Frequently asked questions about PHARMACIE DE LA HAUTE FOLIE

What is the revenue of PHARMACIE DE LA HAUTE FOLIE ?

The revenue of PHARMACIE DE LA HAUTE FOLIE is not publicly disclosed (confidential accounts filed with INPI).

Is PHARMACIE DE LA HAUTE FOLIE profitable?

Yes, PHARMACIE DE LA HAUTE FOLIE generated a net profit of 14 k€ in 2024.

Where is the headquarters of PHARMACIE DE LA HAUTE FOLIE ?

The headquarters of PHARMACIE DE LA HAUTE FOLIE is located in HEROUVILLE SAINT CLAIR (14200), in the department Calvados.

Where to find the tax return of PHARMACIE DE LA HAUTE FOLIE ?

The tax return of PHARMACIE DE LA HAUTE FOLIE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE DE LA HAUTE FOLIE operate?

PHARMACIE DE LA HAUTE FOLIE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.